Stockscreener 앱 받기
63.76
2.75%
-1.805
전일 마감가:
$65.56
열려 있는:
$65
하루 거래량:
1.04M
Relative Volume:
0.56
시가총액:
$3.39B
수익:
-
순이익/손실:
$-38.99M
주가수익비율:
-21.28
EPS:
-2.9966
순현금흐름:
$-24.94M
1주 성능:
+7.68%
1개월 성능:
+6.23%
6개월 성능:
+1.41%
1년 성능:
+25.50%
1일 변동 폭
$63.58
$66.09
1주일 범위
$58.28
$66.09
52주 변동 폭
$41.50
$90.32
Soleno Therapeutics Inc Stock (SLNO) Company Profile
명칭
Soleno Therapeutics Inc
전화
650-213-8444
주소
100 MARINE PARKWAY, SUITE 400, REDWOOD CITY, CA
SLNO을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
SLNO
Soleno Therapeutics Inc
|
63.76 | 3.48B | 0 | -38.99M | -24.94M | -2.9966 |
|
VRTX
Vertex Pharmaceuticals Inc
|
407.79 | 106.37B | 11.39B | 3.64B | 3.50B | 13.99 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
460.46 | 59.90B | 2.46B | -319.09M | -52.09M | -2.4669 |
|
REGN
Regeneron Pharmaceuticals Inc
|
564.63 | 60.40B | 14.21B | 4.46B | 3.56B | 39.69 |
|
ARGX
Argen X Se Adr
|
796.92 | 49.56B | 3.06B | 1.28B | 447.35M | 19.67 |
|
ONC
Beone Medicines Ltd Adr
|
320.10 | 36.88B | 4.56B | -176.77M | 225.30M | -1.7177 |
Soleno Therapeutics Inc Stock (SLNO) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-10-07 | 개시 | Goldman | Buy |
| 2025-08-20 | 개시 | Wells Fargo | Overweight |
| 2025-06-23 | 개시 | TD Cowen | Buy |
| 2025-03-05 | 재개 | Stifel | Buy |
| 2024-12-02 | 재확인 | Robert W. Baird | Outperform |
| 2024-12-02 | 재확인 | Stifel | Buy |
| 2024-09-03 | 개시 | H.C. Wainwright | Buy |
| 2024-05-10 | 개시 | Robert W. Baird | Outperform |
| 2024-02-05 | 개시 | Piper Sandler | Overweight |
| 2024-01-23 | 개시 | Stifel | Buy |
| 2023-11-21 | 재개 | Guggenheim | Buy |
| 2020-09-29 | 개시 | Guggenheim | Buy |
| 2020-01-10 | 개시 | Craig Hallum | Buy |
| 2019-12-23 | 개시 | Oppenheimer | Outperform |
| 2018-02-13 | 재확인 | Maxim Group | Buy |
모두보기
Soleno Therapeutics Inc 주식(SLNO)의 최신 뉴스
Has Soleno Therapeutics Inc. formed a bullish divergenceTrade Volume Report & Low Risk High Win Rate Stock Picks - newser.com
Soleno drops on death of patient treated with Vykat XR - MSN
SLNO Investor News: If You Have Suffered Losses in Soleno - GlobeNewswire
SLNO Investor News: If You Have Suffered Losses in Soleno Therapeutics, Inc. (NASDAQ: SLNO), You Are Encouraged to Contact The Rosen Law Firm About Your Rights - GlobeNewswire Inc.
Soleno Therapeutics stock dips on proposed $200M offering - MSN
Soleno Stock: Blockbuster Launch In Progress (NASDAQ:SLNO) - Seeking Alpha
Soleno Therapeutics (NASDAQ:SLNO) Coverage Initiated by Analysts at The Goldman Sachs Group - MarketBeat
How to use Fibonacci retracement on Soleno Therapeutics Inc.Gap Down & Fast Moving Stock Watchlists - newser.com
Published on: 2025-10-10 05:36:53 - newser.com
Can Soleno Therapeutics Inc. stock deliver sustainable ROEMarket Volume Report & Expert Curated Trade Setup Alerts - newser.com
Multi asset correlation models including Soleno Therapeutics Inc.Chart Signals & Safe Entry Momentum Tips - newser.com
Soleno Therapeutics (SLNO) Drops Amid Critical Scorpion Report -- Hagens Berman - GlobeNewswire
SOLENO (SLNO) REMINDER: Bragar Eagel & Squire, P.C. Reminds - GlobeNewswire
Published on: 2025-10-09 06:36:22 - newser.com
Will Soleno Therapeutics Inc. bounce back from current supportJuly 2025 Gainers & Capital Protection Trading Alerts - newser.com
What Wall Street predicts for Soleno Therapeutics Inc. stock priceAnalyst Downgrade & Weekly High Return Stock Forecasts - newser.com
How to recover losses in Soleno Therapeutics Inc. stockGap Up & Daily Oversold Bounce Ideas - newser.com
Soleno Therapeutics (NASDAQ:SLNO) Given Sell (D-) Rating at Weiss Ratings - MarketBeat
Is Soleno Therapeutics Inc 6XC a good long term investment - earlytimes.in
Piper Sandler Maintains a Buy Rating on Soleno Therapeutics (SLNO), Sets a $145 PT - Yahoo Finance
Soleno Therapeutics (NASDAQ:SLNO) Trading Up 7%Should You Buy? - MarketBeat
Soleno Therapeutics (SLNO): Reassessing Valuation After VYKAT XR Safety Debate and Analyst Support - Yahoo Finance
Goldman Sachs Initiates Soleno Therapeutics at Buy With $125 Price Target - MarketScreener
Soleno Therapeutics Announces Proposed $200 Million Public Offering of Common Stock - GlobeNewswire
Goldman Sachs initiates Soleno Therapeutics stock with Buy rating on Vykat potential - Investing.com
Rosen Law Firm Encourages Soleno Therapeutics, Inc. Investors to Inquire About Securities Class Action InvestigationSLNO - Eastern Progress
Is Soleno Therapeutics Inc. stock supported by strong cash flows - newser.com
Soleno Therapeutics (SLNO) Is Down 8.9% After Short Seller Targets VYKAT XR Safety and Market Potential – Has The Bull Case Changed? - Sahm
How Soleno Therapeutics Inc. stock performs in rate cut cyclesJuly 2025 Analyst Calls & Safe Entry Point Alerts - newser.com
Detecting support and resistance levels for Soleno Therapeutics Inc.Weekly Stock Recap & Verified Entry Point Signals - newser.com
How Soleno Therapeutics Inc. (6XC) stock stacks up against competitorsMarket Performance Summary & Growth Focused Entry Reports - newser.com
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Soleno Therapeutics, Inc.SLNO - Eastern Progress
Soleno Therapeutics (SLNO): Assessing Valuation and Growth Potential in the Biotech Sector - Sahm
Piper Sandler reiterates Overweight rating on Soleno Therapeutics stock - Investing.com
How to escape a deep drawdown in Soleno Therapeutics Inc.Trade Exit Summary & Weekly High Return Forecasts - newser.com
Will Soleno Therapeutics Inc. (6XC) stock justify high valuationJuly 2025 Reactions & Free Growth Oriented Trading Recommendations - newser.com
Stifel Maintains Soleno Therapeutics(SLNO.US) With Buy Rating, Cuts Target Price to $115 - 富途牛牛
What analysts say about Soleno Therapeutics Inc 6XC stockInsider Buying Signals & Low Entry Investment Plans - earlytimes.in
Soleno Therapeutics (NASDAQ:SLNO) Trading Down 9%Here's Why - MarketBeat
Stifel lowers Soleno Therapeutics stock price target to $115 on PWS market model refresh - Investing.com Nigeria
Analysts Offer Insights on Healthcare Companies: Roche Holding AG (OtherRHHVF) and Soleno Therapeutics (SLNO) - The Globe and Mail
Wells Fargo Reiterates a Buy Rating on Soleno Therapeutics (SLNO), Sets a PT of $123 - Insider Monkey
Soleno Therapeutics Inc (SLNO) 재무 분석
매출
순이익
현금흐름
주당 순 이익
Soleno Therapeutics Inc 주식 (SLNO) 내부자 거래
| 내부자 거래 | 관계 | 날짜 | 거래 | 비용 | #주식 | 가치 ($) | #주식 총계 |
|---|---|---|---|---|---|---|---|
| Hirano Patricia C | SEE REMARKS |
Jul 01 '25 |
Sale |
82.76 |
3,830 |
316,971 |
13,206 |
5.74%
자본화:
|
볼륨(24시간):